CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-22 | Pang Phillip EVP & Chief Medical Officer | Sale 10b5-1 | −14,568 | $10.05 | $146K | 250,111 |
| 2024-02-16 | Pang Phillip EVP & Chief Medical Officer | Sale 10b5-1 | −3,321 | $10.24 | $34K | 264,679 |
| 2024-01-02 | Pang Phillip EVP & Chief Medical Officer | Option exercise | +18,833 | $0.86 | $16K | 206,833 |
| 2024-01-02 | Pang Phillip EVP & Chief Medical Officer | Option exercise | +13,576 | $1.58 | $21K | 220,409 |
| 2024-01-02 | Pang Phillip EVP & Chief Medical Officer | Option exercise | +47,591 | $1.53 | $73K | 268,000 |
| 2024-01-02 | Pang Phillip EVP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −18,833 | $0.86 | $16K | 0 |
| 2024-01-02 | Pang Phillip EVP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −13,576 | $1.58 | $21K | 0 |
| 2024-01-02 | Pang Phillip EVP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −47,591 | $1.53 | $73K | 0 |
| 2023-06-07 | Pang Phillip Chief Medical Officer | Option exercise 10b5-1 | +5,000 | $1.53 | $8K | 193,000 |
| 2023-06-07 | Pang Phillip Chief Medical Officer | Sale 10b5-1 | −5,000 | $25.95 | $130K | 188,000 |
| 2023-06-07 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 47,591 | ||
| 2023-02-27 | Pang Phillip Chief Medical Officer | Sale | −8,920 | $23.00 | $205K | 189,400 |
| 2023-02-27 | Pang Phillip Chief Medical Officer | Sale | −1,400 | $23.56 | $33K | 188,000 |
| 2023-02-23 | Pang Phillip Chief Medical Officer | Sale | −2,878 | $25.97 | $75K | 198,320 |
| 2023-02-22 | Pang Phillip Chief Medical Officer | Grant or award | +60,000 | 201,198 | ||
| 2023-02-22 | Pang Phillip Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2023-02-17 | Pang Phillip Chief Medical Officer | Sale | −2,802 | $25.29 | $71K | 141,198 |
| 2023-01-24 | Pang Phillip Chief Medical Officer | Grant or award | +25,406 | $1.58 | $40K | 169,406 |
| 2023-01-24 | Pang Phillip Chief Medical Officer | Grant or award | +4,594 | $5.18 | $24K | 174,000 |
| 2023-01-24 | Pang Phillip Chief Medical Officer | Sale | −30,000 | $30.00 | $900K | 144,000 |
Page 1 of 9 · 165 trades